Sinew Pharma Inc. (TPEX:6634)
35.85
-0.60 (-1.65%)
Mar 4, 2026, 12:00 PM CST
Sinew Pharma Market Cap
Sinew Pharma has a market cap or net worth of 2.6 billion as of March 3, 2026. Its market cap has decreased by -27.12% in one year.
Market Cap
2.60B
Enterprise Value
1.51B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
35.85
Market Cap Chart
Since June 29, 2017, Sinew Pharma's market cap has increased from 1.90B to 2.60B, an increase of 36.75%. That is a compound annual growth rate of 3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 2.60B | -6.90% |
| Dec 31, 2025 | 2.79B | -17.68% |
| Dec 31, 2024 | 3.39B | -29.30% |
| Dec 29, 2023 | 4.80B | -34.51% |
| Dec 30, 2022 | 7.33B | 29.47% |
| Dec 30, 2021 | 5.66B | 19.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syngen Biotech | 3.23B |
| SYN-TECH Chem. & Pharm. | 3.22B |
| 3D Global Biotech | 3.14B |
| Apex Biotechnology | 3.00B |
| GlycoNex Incorporation | 2.75B |
| Synbio Tech | 2.66B |
| Sunny Pharmtech | 2.66B |
| HeXun Biosciences | 2.53B |